{"name":"Zhejiang Anglikang Pharmaceutical Co., Ltd.","slug":"zhejiang-anglikang-pharmaceutical-co-ltd","ticker":"","exchange":"","domain":"","description":"","hq":"","founded":0,"employees":"","ceo":"","sector":"","stockPrice":0,"stockChange":0,"stockChangePercent":0,"marketCap":"","metrics":{"revenue":0,"revenueGrowth":0,"grossMargin":0,"rdSpend":0,"netIncome":0,"cash":0,"dividendYield":0,"peRatio":0,"fiscalYear":"FY2026"},"revenueBreakdown":[],"timeline":[{"date":"2026-07-28","label":"Q2 2026 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2026-10-28","label":"Q3 2026 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2027-01-28","label":"Q4 2027 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2027-04-28","label":"Q1 2027 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2027-07-28","label":"Q2 2027 Earnings","type":"earnings","sentiment":"neutral"},{"date":"2027-10-28","label":"Q3 2027 Earnings","type":"earnings","sentiment":"neutral"}],"diseaseAreas":[{"name":"Other","slug":"other","revenue":0,"percentOfTotal":0,"drugCount":1,"colorKey":"oncology","drugs":[{"name":"Mirogabalin Besilate Tablets","genericName":"Mirogabalin Besilate Tablets","slug":"mirogabalin-besilate-tablets","indication":"Other","status":"phase_1"}]}],"pipeline":[{"name":"Mirogabalin Besilate Tablets","genericName":"Mirogabalin Besilate Tablets","slug":"mirogabalin-besilate-tablets","phase":"phase_1","mechanism":"Small molecule","indications":[],"catalyst":""}],"recentEvents":[],"realNews":[{"url":"https://news.google.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?oc=5","date":"2026-04-02","type":"pipeline","source":"simplywall.st","summary":"Undiscovered Gems in Global Featuring 3 Promising Small Caps - simplywall.st","headline":"Undiscovered Gems in Global Featuring 3 Promising Small Caps","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMiugFBVV95cUxQUEpxRWp4UHZXVnQwcE02Q05CSldsYmlEbmg0NzdHNld5M2NnSUJPRUFYTnlpSGk0dWF0VF9tTGlWblBXOTI1WVNkSy0ybURMdGF1bVljV01KbmU4bURfbUdNNnh6M2t6bS04eHFtRjl0MHNkOVo2c1VzV3NxQ0JSVERjSlVnOFM1RlZIQzJDUGQ4aEF2ZkpEY2JNMm5MQzl6Ql9vdXh0SmxVMElOUmdDbjVubGZuT1gxTUE?oc=5","date":"2026-03-30","type":"pipeline","source":"Markets Mojo","summary":"Zhejiang Anglikang Stock Hits Day High with Strong 7.01% Surge - Markets Mojo","headline":"Zhejiang Anglikang Stock Hits Day High with Strong 7.01% Surge","sentiment":"neutral"},{"url":"https://news.google.com/rss/articles/CBMinwFBVV95cUxOY2xEUDNmQXh5MTRyMWE0SHJ2UGtPVUU2M1BJUEFfUkZkd2F1U3VGcXRaaS1WRWQ0WHZKVWhXWEZJZWdBSGNlWi0zNVRObnExYnk4WU5GcVdRa3B6U0t0YzhJcWtxRk5IWWZyRlEzYzdNSkxlSGtheEU1UXVLWW9tRm03LURnZWRLR3lZVjJ1NzF5QThIankwR1lDX3VtQ0U?oc=5","date":"2018-09-24","type":"regulatory","source":"NAI500","summary":"Zhejiang Anglikang Pharma Approved for $87 Million IPO in Shenzhen - NAI500","headline":"Zhejiang Anglikang Pharma Approved for $87 Million IPO in Shenzhen - NAI500","sentiment":"positive"},{"url":"https://news.google.com/rss/articles/CBMiYkFVX3lxTE94ZzVNMlowWm9pQmpyaGdaV1Vva256WTJ6TWgySTUyTjlhZGg3MFM2amxDNkpDMU5tQV9OWEdhcHpndzlLbl9mWjBYWWFMMmk4SWY3MVczTGQ0T3Z1RHZUQ3ZB?oc=5","date":"2018-03-07","type":"pipeline","source":"Yahoo Finance UK","summary":"Suven Life Sciences Limited (SUVEN.BO) options chain - Yahoo Finance UK","headline":"Suven Life Sciences Limited (SUVEN.BO) options chain","sentiment":"neutral"}],"patents":[],"drugCount":1,"phaseCounts":{"phase_1":1},"enrichmentLevel":0,"visitCount":1,"keyCompetitors":[],"therapeuticFocus":[],"financials":null,"yahoo":null}